Few differences were found for cardiovascular, kidney, and mortality outcomes between liraglutide, semaglutide, and dulaglutide for patients with type 2 diabetes.

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that liraglutide and dulaglutide may have similar kidney protection," she added.

India embraces GLP-1 medications as a major advance in diabetes and obesity care. At AajTak Health Summit, endocrinologist Dr. Ambrish Mithal and Vikrant Shrotriya, Vice President MD, Novo Nordisk ...

GLP-1 receptor agonists have shown promise as treatment for addiction, but there are still several hurdles affecting their ...

At its pharmacy, Costco now offers Ozempic and Wegovy at huge discounts, but are these GLP-1 drugs right for you?

Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific ...

How to find out if weight loss drugs are covered by your insurance, and what to do if they’re not Ozempic (semaglutide), Victoza (liraglutide), and Wegovy (semaglutide) are popular medications used to ...

Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a "weight-inclusive" healthcare company based in Boston, said she would caution against labeling any medication as an "everything ...

Discover how GLP-1 drugs like Ozempic and Mounjaro are transforming the fight against obesity. Learn the science, the risks, and the real-world results from experts on the front lines. Take control of ...

A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...